AP NEWS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14

May 7, 2019

TEL AVIV, Israel, May 07, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, May 14, 2019, to discuss financial results for the first quarter ended March 31, 2019, and provide a corporate update.

Conference Call & Webcast: Tuesday, May 14th @ 8am Eastern Time Within the US: 877-451-6152 Outside the US: 201-389-0879 Conference ID: 13689927 Webcast: http://public.viavid.com/index.php?id=134146

About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.

InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.

Investor Contacts:Craig ShoreChief Financial OfficerInspireMD, Inc.888-776-6804 craigs@inspiremd.com

Jeremy FefferLifeSci Advisors, LLC212-915-2568 jeremy@lifesciadvisors.com